Skip to main content
TipRanks
Go Ultimate75% OFF

Diamedica Therapeutics (DMAC) Ownership - Who Owns Diamedica Therapeutics?

573 Followers

Diamedica Therapeutics (DMAC) Ownership Overview

The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. Approximately 7.16% of the company’s stock is owned by Institutional Investors, 17.80% is owned by Insiders, and 75.04% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Dec 07, 2025Jan Stahlberg$7,624,976

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DMAC top shareholders
Holder# of SharesType% HoldingValue
Jan Stahlberg8,825,742Insider16.36%77,578,272
Ishares1,394,853Institution2.59%12,260,758
Vanguard617,239Institution1.14%5,425,531
Randall Michael Giuffre445,230Insider0.83%3,913,572
Fidelity Salem Street Trust438,618Institution0.81%3,855,452
Vanguard Index Funds355,523Institution0.66%3,125,047
Fidelity Concord Street Trust325,496Institution0.60%2,861,110
Vanguard Scottsdale Funds252,270Institution0.47%2,217,453
Dietrich John Pauls128,791Insider0.24%1,132,073
Schwab Capital Trust101,638Institution0.19%893,398

Top Mutual Fund Holders

DMAC top mutual fund holders
Holder# of SharesType% HoldingValue
Fidelity Salem Street Trust438,618Institution0.81%3,855,452
Vanguard Index Funds355,523Institution0.66%3,125,047
Fidelity Concord Street Trust325,496Institution0.60%2,861,110
Vanguard Scottsdale Funds252,270Institution0.47%2,217,453
Schwab Capital Trust101,638Institution0.19%893,398
Jacob Funds Inc.87,730Institution0.16%771,147
Tiaa-cref Funds48,349Institution0.09%424,988
Goldman Sachs Trust32,817Institution0.06%288,461
Valic Co I14,282Institution0.03%125,539
State Street Institutional Investment Trust11,200Institution0.02%98,448

Top ETF Holders

DMAC top ETF holders
Holder# of SharesType% HoldingValue
iShares Russell 2000 ETF, IWM ETF935,347Institution1.73%8,221,700
Vanguard Extended Market ETF, VXF ETF360,556Institution0.67%2,981,798
iShares Russell 2000 Growth ETF, IWO ETF348,101Institution0.65%3,059,808
Vanguard Russell 2000 ETF, VTWO ETF213,590Institution0.40%1,766,389
iShares Micro-Cap ETF, IWC ETF111,405Institution0.21%979,250
Vanguard Russell 2000 Growth ETF, VTWG ETF40,513Institution0.08%335,043
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR, FR:R2EH ETF40,434Institution0.07%377,249
Global X Russell 2000 ETF, RSSL ETF17,416Institution0.03%162,491
Invesco Russell 2000 UCITS ETF, GB:RTYS ETF3,976Institution<0.01%37,100
Vanguard Russell 3000 ETF, VTHR ETF2,407Institution<0.01%19,906

FAQ

Who Owns Diamedica Therapeutics (DMAC)?
According to the latest TipRanks data, approximately 7.16% of the company's stock is held by institutional investors, 17.80% is held by insiders, and 75.04% is held by public companies and individual investors.
What percentage of Diamedica Therapeutics (DMAC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.16% of Diamedica Therapeutics (DMAC) stock is held by institutional investors: 3.18% by mutual funds and 3.98% by ETFs.
What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.04% of Diamedica Therapeutics (DMAC) stock is held by public companies and individual investors.
Who owns the most shares of Diamedica Therapeutics (DMAC)?
JAN STAHLBERG owns the most shares of Diamedica Therapeutics (DMAC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.